A phase II study of erlotinib in combination with capecitabine in previously treated patients with metastatic pancreatic cancer
Blaszkowsky LS, Kulke MH, Ryan DP, Clark JW, Meyerhardt J, Zhu AX, Lawrence C, Fuchs CS. A phase II study of erlotinib in combination with capecitabine in previously treated patients with metastatic pancreatic cancer. Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings, Part I of II. 2005; 23(16S ):A4099.